Latest Convertible Bonds News

Page 1 of 3
Sigma Lithium has completed a US$125 million convertible bond issue, replacing roughly US$100 million of expensive secured debt due in 2027 with unsecured funding maturing in 2031. The refinancing lowers the stated coupon from 11.45% floating to 7.00% fixed and was increased by 25% after investor demand.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Sigma Lithium reported US$51.3 million of operating cash flow for the first nine months of 2026 while pricing a US$125 million convertible bond to refinance short-term debt. Third-quarter revenue fell after operational suspensions, but the company says production has resumed and its 330,000-tonne 2027 target remains intact.
Maxwell Dee
Maxwell Dee
16 Nov 2026
Sigma Lithium has launched a US$100 million convertible bond to replace expensive secured debt and push its main repayment risk into 2029 and 2031. The financing arrives as operations recover from a Brazilian suspension that cut third-quarter production but left the company reporting a 32% gross margin.
Maxwell Dee
Maxwell Dee
3 Nov 2026
Lynas Rare Earths has reported its strongest September quarter in years, with sales revenue reaching A$310.1 million and NdPr production hitting a record 2,082 tonnes. The company is also advancing its Meteoric Resources acquisition and other supply-chain investments, although planned Malaysian maintenance will weigh on the December quarter.
Maxwell Dee
Maxwell Dee
29 Oct 2026
Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.
Ada Torres
Ada Torres
20 Aug 2026
Telix Pharmaceuticals reported a 21% year-on-year revenue jump to US$247 million in Q2 2026, buoyed by strong Precision Medicine sales and a new Regeneron partnership. The company also secured FDA alignment on a pivotal prostate cancer trial and expanded its manufacturing footprint.
Ada Torres
Ada Torres
21 July 2026
Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.
Ada Torres
Ada Torres
14 Apr 2026
Provaris Energy reported a 59% increase in its half-year loss to $2.09 million, driven by higher project development costs amid progress in hydrogen and carbon capture technologies. The company raised over $3.5 million in capital and is advancing key milestones for its hydrogen shipping and liquid CO2 tank projects.
Maxwell Dee
Maxwell Dee
27 Feb 2026
Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.
Ada Torres
Ada Torres
20 Feb 2026
Provaris Energy has made significant strides in hydrogen and liquid carbon dioxide storage technologies, reinforcing key partnerships and securing funding to meet critical 2026 milestones.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Provaris Energy has advanced its hydrogen and carbon dioxide storage technologies through strategic partnerships and a new Norwegian fabrication facility, setting the stage for commercialisation in European energy markets.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Brickworks Limited shareholders convened on 10 September 2025 to vote on a landmark merger with Washington H. Soul Pattinson, creating a new ASX-listed entity, Topco. The deal promises streamlined ownership and enhanced growth prospects.
Maxwell Dee
Maxwell Dee
10 Sept 2025

Browse the archive

Full archive